Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders' Deficit (Details)

v3.25.1
Stockholders' Deficit (Details)
12 Months Ended
Oct. 17, 2024
May 22, 2024
USD ($)
Sep. 28, 2023
USD ($)
$ / shares
shares
Dec. 31, 2024
item
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Oct. 31, 2024
shares
Oct. 07, 2024
$ / shares
May 19, 2024
$ / shares
shares
Jul. 14, 2023
USD ($)
$ / shares
Dec. 16, 2020
$ / shares
shares
Subsidiary, Sale of Stock [Line Items]                    
Preferred stock authorized (in shares)       1,997,786 2,000,000 2,000,000       2,000,000
Preferred stock, par value (in dollars per share) | $ / shares       $ 0.0001 $ 0.0001         $ 0.0001
Temporary Equity, Shares Authorized       2,213.8044 0 2,213.8044        
Temporary Equity, Shares Issued       2,213.8044 0          
Temporary Equity, Shares Outstanding       2,213.8044 0          
Preferred stock issued (in shares)       0 0          
Preferred stock outstanding (in shares)       0            
Common and preferred stock authorized (in shares)                   45,000,000
Common stock authorized (in shares)       43,000,000 43,000,000         43,000,000
Common stock reserved for the future issuance       22,359,995            
Common stock, par value (in dollars per share) | $ / shares       $ 0.0001 $ 0.0001         $ 0.0001
Number of votes per common stock | item       1            
Net proceeds from issuance of common stock | $         $ 1,156,443          
Series A Non-Voting Convertible Preferred Stock                    
Subsidiary, Sale of Stock [Line Items]                    
Preferred stock dividend rate percentage       5.00%            
Percentage of original shares remaining issued and outstanding       30.00%            
Shares automatically converted       10,000            
Preferred Stock                    
Subsidiary, Sale of Stock [Line Items]                    
Temporary Equity, Shares Authorized       2,213.8044            
Temporary Equity, Shares Outstanding       2,213.8044            
Pharmagesic Holdings Inc.                    
Subsidiary, Sale of Stock [Line Items]                    
Preferred stock, par value (in dollars per share) | $ / shares             $ 0.0001      
Number of Contingent Value Rights Issuable for each Common Share 1                  
Contingent Value Rights Agreement Term 7 years                  
Percentage of upfront payment to which holders are entitled 87.75%                  
Percentage ownership of outstanding rights that entitles holder to audit and enforcement 30.00%                  
Capital on Demand Sales Agreement                    
Subsidiary, Sale of Stock [Line Items]                    
Common stock, par value (in dollars per share) | $ / shares                 $ 0.0001  
Aggregate offering price | $                 $ 6,700,000  
Shares issued     25,675              
Share price | $ / shares     $ 52.78              
Proceeds from issuance of shares on ATM, net of fees | $     $ 1,355,090              
Offering costs | $     198,650              
Net proceeds from issuance of common stock | $     $ 1,156,440              
Public Offering | Maxim Group LLC                    
Subsidiary, Sale of Stock [Line Items]                    
Share price | $ / shares               $ 5    
Proceeds from issuance of shares on ATM, net of fees | $   $ 1,700,000                
Issuance of common stock at a public offering               340,000    
Net proceeds from issuance of common stock | $   $ 1,382,170